SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-24-006614
Filing Date
2024-01-11
Accepted
2024-01-11 16:18:05
Documents
16
Period of Report
2023-10-30
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A d22567d8ka.htm   iXBRL 8-K/A 30286
2 EX-23.1 d22567dex231.htm EX-23.1 2690
3 EX-99.1 d22567dex991.htm EX-99.1 340862
4 EX-99.2 d22567dex992.htm EX-99.2 312261
5 EX-99.3 d22567dex993.htm EX-99.3 292922
  Complete submission text file 0001193125-24-006614.txt   1229231

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA alrn-20231030.xsd EX-101.SCH 2514
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE alrn-20231030_lab.xml EX-101.LAB 18663
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alrn-20231030_pre.xml EX-101.PRE 11674
10 EXTRACTED XBRL INSTANCE DOCUMENT d22567d8ka_htm.xml XML 5659
Mailing Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451
Business Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451 617-995-0900
AILERON THERAPEUTICS INC (Filer) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38130 | Film No.: 24529460
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)